Major Pharmaceuticals initiated a voluntary recall of its levothyroxine sodium tablets on July 13 after the Food and Drug Administration determined the pills were subpotent, meaning they deliver less medication than labeled.
Major Pharmaceuticals initiated a voluntary recall of its levothyroxine sodium tablets on July 13 after the Food and Drug Administration determined the pills were subpotent, meaning they deliver less medication than labeled.
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.© 2026 American Thyroid Association.
